Literature DB >> 16416269

Critical comment: analyzing the effect of novel therapies on cytokine expression in inflammatory bowel disease: do cytokine levels reflect clinical response?

B M Wittig1, M Zeitz.   

Abstract

Over the past several years, research in the field of cytokine production and function has become indispensable to understand the immunopathology of chronic intestinal inflammation. Thereupon, clinical studies analyzing cytokine production have generated a tremendous amount of data. In patients with inflammatory bowel disease, several studies examined pro-inflammatory cytokines in gut tissue and plasma, but a clear interpretation of the results with respect to disease activity or therapeutic response has been hampered by patient- and sample-related pitfalls.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16416269     DOI: 10.1007/s00384-005-0082-5

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  17 in total

1.  Soluble interleukin 2 and CD8 and CD4 receptors in inflammatory bowel disease.

Authors:  T Matsuura; G A West; J S Klein; L Ferraris; C Fiocchi
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

2.  Down-regulation of interferon-gamma parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease: a 12-month follow-up study.

Authors:  V Muratov; J Lundahl; A K Ulfgren; K Elvin; I Fehrman; N Ahlborg; A Ost; N Hittel; A Saniabadi; R Löfberg
Journal:  Int J Colorectal Dis       Date:  2006-03-15       Impact factor: 2.571

3.  Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.

Authors:  C Niederau; F Backmerhoff; B Schumacher; C Niederau
Journal:  Hepatogastroenterology       Date:  1997 Jan-Feb

4.  Local and systemic liberation of proinflammatory cytokines in ulcerative colitis.

Authors:  M Gotteland; M Lopez; C Muñoz; R Saez; H Altshiller; P Llorens; O Brunser
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

Review 5.  Cytokines in intestinal inflammation: pathophysiological and clinical considerations.

Authors:  R B Sartor
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

6.  Intracellular cytokine patterns of peripheral blood T cells as a useful indicator of activeness of Crohn's disease.

Authors:  Yoshio Ogura; Yuji Imamura; Yoshiaki Murakami; Yoshio Takesue; Takashi Yokoyama; Taijiro Sueda; Eiso Hiyama
Journal:  Hiroshima J Med Sci       Date:  2005-03

7.  Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome.

Authors:  Dirk Raddatz; Miriam Bockemühl; Giuliano Ramadori
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-05       Impact factor: 2.566

Review 8.  Immunomodulatory therapy for inflammatory bowel disease.

Authors:  Kazuo Kusugami; Kenji Ina; Takafumi Ando; Kenji Hibi; Yuji Nishio; Hidemi Goto
Journal:  J Gastroenterol       Date:  2004-12       Impact factor: 7.527

9.  Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column.

Authors:  Koji Sawada; Tetsuichiro Muto; Takashi Shimoyama; Masamichi Satomi; Toshio Sawada; Hirokazu Nagawa; Nobuo Hiwatashi; Hitoshi Asakura; Toshifumi Hibi
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

10.  High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis.

Authors:  Y R Mahida; L Kurlac; A Gallagher; C J Hawkey
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

View more
  2 in total

1.  Is lymphatic status related to regression of inflammation in Crohn's disease?

Authors:  Francesco Tonelli; Francesco Giudici; Gadiel Liscia
Journal:  World J Gastrointest Surg       Date:  2012-10-27

Review 2.  Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future.

Authors:  Xiu-Li Chen; Jing-Wei Mao; Ying-De Wang
Journal:  World J Gastrointest Pathophysiol       Date:  2020-05-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.